测定甘草酸二铵注射液的药物稳定性。
To determine constancy of Diammonium Glycyrrhizinate injection.
结论：甘草酸二铵治疗寻常型银屑病安全有效。
Conclusion: DG is effective and safe in the treatment patients with psoriasis vulgaris.
目的：观察甘草酸二铵治疗寻常型银屑病的临床疗效和安全性。
Objective:To observe the clinical effect and safety of diammonium glycyrrhetate(DG) in the treatment of psoriasis vulgaris.
目的研究甘草酸二铵(DG)对染镉小鼠肝脂质过氧化损伤的保护作用。
Objective To study the protecting effect of diammonium glycyrrhizinate (DG) on cadmium-induced lipid peroxidation in liver of mice.
目的：观察新一代甘草酸制剂甘草酸二铵脂质配位体（DGLL）对酒精性脂肪肝的治疗作用。
AIM:To study the therapeutic effect of Diammonium Glycyrrhizinate lipid ligand(DGLL) on alcoholic fatty liver.
目的：评价甘草酸二铵磷脂复合物注射剂(DG - PC)的对急性、慢性免疫性肝脏损害的保护作用。
Objective: To investigate the protective effects of diammonium glycyrrhizinate phospholipid complex injection (DG-PC) on acute and chronic-immunological liver injury.
前言：目的：研究甘草酸二铵注射液对细菌内毒素检查实验的干扰情况，并建立其细菌内毒素检查的质量标准。
Objective: to study the interference of Diammonium Glycyrrhizinate Injection in bacterial endotoxin test and to establish a bacterial endotoxin test method for the sample.
结果：多烯磷脂酰胆碱注射液与甘草酸二铵氯化钠注射液配伍实验时，无论是原液或稀释液均没有出现性状外观变化。
Results: While experimenting on polyene phosphatidylcholine injection and diammonium glycyrrhizinate injection, neither liquid nor diluent had changes in the appearance of the characters.
本发明提供了一种药物组合物及该药物组合物的药用制剂，该组合物及其药物制剂由治疗剂量的甘草酸二铵的两个差相异构体组成。
The present invention provides one kind of medicine composition and its medicine preparation. The medicine composition consists of two isomers of diammonium glycyrrhizinate.
结果：复方甘草酸苷组与甘草酸二铵组总有效率分别为79 49 %和75 68 % ，两组间无显著性差异（P>0 05） ；
RESULTS:The total effective rates of GL group and GX group were79.49%and75.68%respectively without significant difference(P>0.05).
结果：复方甘草酸苷组与甘草酸二铵组总有效率分别为79 49 %和75 68 % ，两组间无显著性差异（P>0 05） ；
RESULTS:The total effective rates of GL group and GX group were79.49%and75.68%respectively without significant difference(P>0.05).
应用推荐